Le Lézard
Classified in: Science and technology
Subject: IPO

TDCX Files Registration Statement for Proposed Initial Public Offering


8 September 2021 -- TDCX Inc. ("TDCX" or the "Company"), a high-growth digital customer experience solutions provider for innovative technology and blue-chip companies, today announced that it has filed a Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission in connection with the proposed initial public offering ("IPO") of American Depositary Shares ("ADS") representing its Class A ordinary shares. The Company intends to list the ADSs on the New York Stock Exchange under the symbol "TDCX".

The number of ordinary shares to be represented by each ADS, the number of ADS to be offered and the price range for the proposed offering have not yet been determined.

Goldman Sachs & Co. LLC and Credit Suisse Securities (USA) LLC will serve as the joint bookrunners for the proposed offering.

The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from:

Goldman Sachs & Co. L.L.C.

200 West Street

New York, NY 10282-2198

Attention: Prospectus Department (1-866-471-2526)

Email: [email protected]

Credit Suisse Securities (USA) L.L.C.

6933 Louis Stephens Drive

Morrisville, NC 27560

Attention: Prospectus Department (1-800-221-1037)

Email: [email protected]

The Form F-1 Registration Statement and all subsequent amendments may be accessed through the SEC's website at www.sec.gov.

A Registration Statement on Form F-1 relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective.

These ADSs may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective under the Securities Act of 1933, as amended. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. The securities referred to herein have not been and will not be registered under the applicable securities laws of any jurisdiction outside of the United States of America.

About TDCX

TDCX is a high-growth digital customer experience solutions provider for innovative technology and other blue-chip companies. The Company offers omnichannel CX solutions, sales and digital marketing services and content monitoring and moderation services. The Company has a track record of success with clients in travel and hospitality, digital advertising and media, fast-moving consumer goods, technology, financial services, fintech, government and non-governmental organisations, gaming, e-commerce and education. TDCX has an international footprint with offices in Singapore, Malaysia, Thailand, the Philippines, China, Japan, India, Romania, Spain and Colombia, and services its clients' customers globally in more than 20 languages. TDCX has won over 270 awards.

Forward-looking statements

This announcement may contain forward?looking statements that reflect TDCX's current expectations regarding future events. A list and description of risks, uncertainties and other risks associated with an investment in TDCX can be found in TDCX's filings with the United States Securities and Exchange Commission, including the Form F?1 Registration Statement. Investors are cautioned not to place undue reliance on these forward?looking statements, which speak only as of the date hereof. TDCX undertakes no obligation to update or revise the information contained in this announcement, whether as a result of new information, future events or circumstances or otherwise.


These press releases may also interest you

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:18
SK Telecom today announced a collaboration with Aptos Labs, Brevan Howard, and Microsoft to deliver to the global financial market Aptos Ascend, a suite of end-to-end institutional solutions including a permissioned network and Digital Asset...

at 21:00
On the 17th of April 2024, the Centre for Trusted Internet and Community (CTIC) at the National University of Singapore (NUS) launched a groundbreaking new initiative, "Living Well Digitally" (https://ctic.nus.edu.sg/living-well-digitally/)....

at 20:50
MiniTool Software Limited has released a new version of its video making program ? MiniTool MovieMaker 7.3.0 with brand-new resources to decorate videos effortlessly....

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 20:00
OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, today announced its participation in the 'Runes Incubator.' This program, initiated by OnePiece Labs and supported by Merlin Chain and Franklin Templeton,...



News published on and distributed by: